ImmuCell Q2 EPS $(0.18) Down From $(0.09) YoY, Sales $3.53M Down From $3.86M YoY
Portfolio Pulse from bharat@benzinga.com
ImmuCell (NASDAQ:ICCC) reported Q2 losses of $(0.18) per share, a 100% increase from $(0.09) per share YoY. Sales also decreased by 8.50% to $3.53 million from $3.86 million YoY.
August 10, 2023 | 8:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ImmuCell's Q2 earnings report shows a significant increase in losses and a decrease in sales YoY, which could negatively impact the stock price.
ImmuCell's increased losses and decreased sales indicate a negative financial performance. This could lead to a decrease in investor confidence, potentially driving the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100